Ketamine-Assisted Psychotherapy — KAP — has gotten a lot of attention in recent years, and with that attention has come a fair amount of confusion about what it actually is, who it’s appropriate for, and how it works in a clinical setting. We want to give you a straight answer on all of that, including the parts where we have to be honest that this isn’t the right path for everyone.
What Ketamine-Assisted Psychotherapy Is — And What It Isn’t
KAP combines a medically supervised ketamine session with psychotherapy — before, during, and after the medicine experience. The ketamine itself is not a cure. It creates a window of neurological and psychological flexibility that, when supported by skilled therapeutic work, can allow people to process things that have been difficult or impossible to access otherwise.
Ketamine is an FDA-approved anesthetic medication, but we need to be clear: its use in treating depression, anxiety, PTSD, and related conditions is off-label. It is not FDA-approved for these indications. The research base is growing — studies published in journals including the American Journal of Psychiatry and Biological Psychiatry have documented meaningful short-term reductions in depression symptoms, including in people who have not responded to multiple antidepressants — but KAP is not a mainstream first-line treatment, and we don’t present it that way. Results vary by individual, and not everyone responds.
Who KAP May Be Appropriate For
KAP is typically considered for people who have already tried conventional treatment — therapy, medication, or both — without adequate relief. The clinical literature most consistently supports its use in treatment-resistant depression, though people dealing with PTSD, chronic anxiety, and grief have also reported benefit.
This is not a path we recommend as a starting point. If you haven’t yet tried individual therapy or medication management, those are the right first steps. KAP is intensive, requires a significant commitment of time and energy, and works best when embedded within an ongoing therapeutic relationship rather than as a standalone procedure.
We also want to be direct: KAP isn’t covered by most insurance plans at this time. We’ll give you clear information about costs before you commit to anything.
How the Process Works at Our Ruckersville Location
The KAP process at Life Works begins with what we call preparatory sessions — one or more therapy appointments where we spend time understanding your history, your intentions, and what you’re hoping the experience might open up. We don’t rush this part. The quality of the therapeutic work surrounding the ketamine session shapes what you’re able to do with the experience.
The medicine session itself takes place in a safe, supported setting. You’ll be monitored throughout. Most sessions last between two and three hours, including time to rest and process afterward. We use music, an eye mask, and a calm environment intentionally — these elements support the inner experience.
After the session, integration is where much of the real work happens. The insights and emotional openings that can emerge during a ketamine session are not automatically therapeutic — they need to be worked with in therapy. We schedule integration sessions in the days and weeks following the medicine experience specifically for this reason. Discuss with your provider what an appropriate integration schedule looks like for your situation.
Barriers to Care — Let’s Be Honest
“I’m nervous about losing control or having a bad experience.”
This is a legitimate concern, and we don’t brush past it. Ketamine can produce a dissociative experience — a sense of being detached from your usual sense of self and surroundings. For some people, this is disorienting. For others, it’s deeply meaningful. We prepare you carefully for what the experience may be like, and we’re present throughout. The goal is a contained, supported experience — not something that happens to you without guidance. That said, we can’t guarantee how your body and mind will respond. That’s why the preparation and the relationship with your therapist matter so much.
“I’ve heard ketamine described as a party drug — is this the same thing?”
It’s the same molecule, yes. Ketamine has been used recreationally, and it does have a history of misuse. What distinguishes KAP is the intentional clinical structure around it — the doses used therapeutically, the setting, the preparation, and the integration work that follows. A scalpel and a kitchen knife are both blades; context and training change what they do. We understand the hesitation, and we encourage you to ask every question you have before making a decision about whether this is right for you.
If you’re curious about how specialized therapies like KAP fit alongside other approaches we offer, our Specialized Therapies & Wellness Services page provides a broader overview of what’s available at Life Works.
A Note on SPRAVATO®
If you’re exploring ketamine-based treatments, you may have also heard about SPRAVATO® (esketamine). SPRAVATO® is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior, and it is a distinct treatment from KAP. SPRAVATO® is administered as a nasal spray in a certified provider’s office and is covered by many insurance plans. If you’re weighing your options, we’re happy to explain the differences and help you think through what makes sense for your situation. If SPRAVATO® seems to be a better fit for your unique circumstances, we’ll get you connected to a REMS approved clinic near you to explore treatment.
Frequently Asked Questions
Is ketamine legal for treating depression and anxiety?
Ketamine is an FDA-approved anesthetic medication, but its use for depression, anxiety, and PTSD is off-label — meaning it is not FDA-approved for those specific indications. Prescribing off-label is legal and common in medicine, but it means you’re using a medication outside its originally approved scope. We explain this clearly before any treatment begins.
How many KAP sessions will I need?
There’s no universal answer. Some protocols involve a series of sessions — often three to six — with integration therapy woven throughout. Others involve fewer sessions with a strong emphasis on the surrounding therapeutic work. We build a plan based on your specific situation, your history, and how you respond. We don’t upsell additional sessions without a clear clinical reason.
Can I do KAP if I’m currently on antidepressants?
Some medications interact with ketamine in ways that may affect the experience or its safety. The prescribers we partner with are experts in understanding what medications may not be safe with ketamine. They will provide guidance and direction on how to proceed to ensure you have a safe experience.
Will insurance cover KAP?
Most insurance plans do not currently cover Ketamine-Assisted Psychotherapy. The therapy sessions surrounding the medicine can sometimes be billed to insurance, but the ketamine itself typically is not reimbursed. We’ll give you a clear cost breakdown upfront. If cost is a concern, SPRAVATO® may be an option worth discussing, as it carries FDA approval and is covered by many insurance plans.
Is KAP available at the Ruckersville location?
Yes. KAP is available at our Ruckersville location at 8767 Seminole Trail, Suite 101, Ruckersville, VA 22968. Please call 434-266-6467 to ask about scheduling a consultation. We can also meet with anyone in the State of Virginia via video sessions to offer KAP.
Key Takeaways
- KAP combines medically supervised ketamine with before, during, and after psychotherapy — the medicine alone is not the treatment.
- Ketamine’s use for depression, anxiety, and PTSD is off-label, not FDA-approved for these indications — we are transparent about this.
- KAP is generally considered after conventional treatments haven’t provided adequate relief — it’s not a first-line approach.
- Integration therapy following the medicine session is where much of the lasting therapeutic work occurs.
- If you’ve been living with depression, anxiety, or trauma that hasn’t responded to previous treatment, KAP may be worth exploring. We’re not here to sell you on it — we’re here to give you real information so you can make an informed decision. Call us at 434-266-6467 or schedule a consultation at our Ruckersville location.
References
American Psychiatric Association. (2017). Consensus statement on the use of ketamine in the treatment of mood disorders. https://doi.org/10.1001/jamapsychiatry.2017.0080
DailyMed. (n.d.). KETALAR — ketamine hydrochloride injection, solution. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b2bdc5c-70c2-4f74-b7e7-991c5528044f
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D. V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J. G., Lee, Y., Lui, L. M. W., Mansur, R. B., Papakostas, G. I., … Stahl, S. (2021). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. American Journal of Psychiatry, 178(5), 383–399. https://doi.org/10.1176/appi.ajp.2020.20081251
National Institute of Mental Health. (n.d.). Depression. https://www.nimh.nih.gov/health/topics/depression
National Institute of Mental Health. (n.d.). Post-traumatic stress disorder. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & APA Council of Research Task Force on Novel Biomarkers and Treatments. (2015). Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression. American Journal of Psychiatry, 172(10), 950–966. https://doi.org/10.1176/appi.ajp.2015.15040465
SPRAVATO® REMS. (n.d.). SPRAVATO® indication. https://www.spravatorems.com/
Yavi, M., Lee, H., Henter, I. D., Park, L. T., Zarate, C. A., Jr., & Mathews, D. C. (2022). Ketamine treatment for depression: A review. Discover Mental Health, 2, 9. https://doi.org/10.1007/s44192-022-00012-3
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. The services described, including individual therapy, medication management, and Ketamine-Assisted Psychotherapy, may not be appropriate for every individual and should only be pursued under the guidance of a qualified mental health or medical provider familiar with your full history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.